» Articles » PMID: 2783707

Thymic Stroma-derived T Cell Growth Factor (TSTGF). IV. Capacity of TSTGF to Promote the Growth of L3T4- Lyt-2- Thymocytes by Synergy with Phorbol Myristate Acetate or Various IL

Overview
Journal J Immunol
Date 1989 Feb 15
PMID 2783707
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The present study investigates the role of thymic stroma-derived T cell growth factor (TSTGF) in promoting the growth of L3T4- Lyt2- (double-negative) thymocytes. Partially purified TSTGF samples were prepared from the culture supernatant of a newly established thymic stromal cell line, MRL104.8a. The TSTGF alone induced only marginal proliferation of double-negative thymocytes, whereas this factor exerted a potent growth-promoting effect on these cells in combination with PMA. Because such an enhanced proliferation was not inhibited by anti-IL-4 or anti-IL-2R antibody, this was not due to the stimulation of an autocrine mechanism involving the production and utilization of IL-4 or IL-2. In scrutinizing PMA-equivalent physiologic substance(s), IL-1 was revealed to be capable of replacing the role of PMA in the above co-stimulation cultures and including enhanced proliferation of double-negative thymocytes in combination with TSTGF. Although TSTGF plus IL-2 or IL-4 also exhibited an appreciable or moderate synergistic effect on the growth of double-negative thymocytes, its magnitude was weaker compared with that obtained by TSTGF plus IL-1. More important, the strikingly enhanced proliferation was induced in the combinations of TSTGF, IL-1, and IL-2 or IL-4 under conditions in which the proliferation induced by IL-1 plus IL-4 or IL-1 plus IL-2 was marginal or slight. Furthermore, such strongly enhanced proliferation was also observed in the double-negative thymocyte population which was additionally depleted of T3+ cells (namely, the L3T4- Lyt-2- T3- or dull population). These results indicate the crucial role of TSTGF in the proliferation of immature thymocytes by synergy with various cytokines.

Citing Articles

Model for clonal elimination in the thymus.

Kosaka H, Ogata M, Hikita I, Maruo S, Sugihara S, Matsubara H Proc Natl Acad Sci U S A. 1989; 86(10):3773-7.

PMID: 2524833 PMC: 287222. DOI: 10.1073/pnas.86.10.3773.


Differentiation of thymocytes from CD3-CD4-CD8- through CD3-CD4-CD8+ into more mature stages induced by a thymic stromal cell clone.

Tatsumi Y, Kumanogoh A, Saitoh M, Mizushima Y, Kimura K, Suzuki S Proc Natl Acad Sci U S A. 1990; 87(7):2750-4.

PMID: 2138784 PMC: 53768. DOI: 10.1073/pnas.87.7.2750.


An in vitro model for cyclosporin A-induced interference of intrathymic clonal elimination.

Kosaka H, Matsubara H, Sogoh S, Ogata M, Hamaoka T, Fujiwara H J Exp Med. 1990; 172(1):395-8.

PMID: 2113566 PMC: 2188159. DOI: 10.1084/jem.172.1.395.


DNA strand breaks and death of thymocytes induced by N-methyl-N-nitrosourea.

Ogiu T, Fukami H, Nishimura M J Cancer Res Clin Oncol. 1992; 118(1):23-9.

PMID: 1729257 DOI: 10.1007/BF01192307.


Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigens.

Shimizu J, Suda T, Katagiri T, Fujiwara H, Hamaoka T Jpn J Cancer Res. 1992; 83(2):184-93.

PMID: 1372887 PMC: 5918790. DOI: 10.1111/j.1349-7006.1992.tb00085.x.